Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag for thrombocytopenic adults with hepatitis C eligible for antiviral therapy
2006-004946-17Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in hepatitis C virus infection comparing Eltrombopag with Placebo (2 arms). Primary endpoint: Sustained virologic response. Started Sep 2007; status: completed.
02
Drugs
eltrombopag
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2006-004946-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004946-17.